Descripción general
¿Qué es S&P 500 Q2 2026 Earnings Season: Record Profits as AI Monetisation Arrives?
The S&P 500 Q2 2026 earnings season, which kicked off in mid-July with the major banks and accelerated through the second half of the month, delivered the strongest aggregate earnings growth the index had seen since Q2 2023. With approximately 60% of S&P 500 companies having reported by the final week of July, blended earnings growth stood at 14.7% year-over-year — comfortably ahead of the 9.8% consensus estimate that analysts had set entering the season.
The standout narrative was the arrival of meaningful AI revenue monetisation at scale. For the past three years, markets had priced in enormous expectations for AI-driven revenue growth at the major technology platforms, but the actual reported figures had consistently been described as "coming soon" or "gaining traction." Q2 2026 marked a decisive turning point. Microsoft reported that its AI-powered Copilot products contributed over $12 billion in incremental quarterly revenue — double the level of Q2 2025. Alphabet disclosed that AI Overviews in Google Search had increased advertising revenue per query by 18%, adding approximately $4 billion in incremental quarterly revenue. Meta reported that its AI-driven content recommendation and ad-targeting systems had lifted advertiser return on investment to record levels, translating directly into accelerated ad spend on its platforms.
The technology sector as a whole reported earnings growth of 28.4% year-over-year in Q2 2026 — its best quarter since the pandemic-era digital acceleration of 2021. Margins expanded significantly as AI infrastructure investments made in 2024 and 2025 began to yield operating leverage: the cost of serving AI-generated content fell faster than the revenue it generated, a dynamic that management teams described as a structural rather than cyclical improvement.
Outside technology, the earnings picture was more mixed but broadly encouraging. The financial sector benefited from a steepening yield curve and a continued decline in loan loss provisions as credit quality remained robust despite lingering inflation. Major banks — JPMorgan Chase, Bank of America, and Wells Fargo — all reported net interest income growth and raised full-year guidance. Consumer discretionary companies posted solid but unspectacular results, with travel and hospitality outperforming while big-box retail grappled with inventory management challenges and softening demand for large-ticket items.
Healthcare was a notable sector-specific story in Q2 2026. Several large pharmaceutical companies reported strong results driven by GLP-1 drugs (obesity and diabetes treatments) — a category that has become one of the fastest-growing in pharmaceutical history. Novo Nordisk and Eli Lilly both exceeded earnings estimates by wide margins, and the healthcare sector's overall earnings growth of 16.2% for Q2 2026 significantly outperformed historical norms.
The energy sector was a drag on aggregate S&P 500 earnings. With oil prices hovering around $75 per barrel — down from the $90+ levels of mid-2025 — energy company profits fell approximately 12% year-over-year. However, the sector's declining weight in the S&P 500 (now below 4%) meant the impact on index-level earnings was limited.
For traders and portfolio managers, Q2 2026 earnings season reinforced several themes that had been building for months: the AI monetisation trade had arrived in earnest, financial sector leverage to yield-curve normalisation was playing out as expected, and healthcare's structural growth narrative around GLP-1 drugs remained compelling. Earnings-surprise momentum — buying companies that beat estimates and raise guidance — was a rewarding strategy throughout the reporting season.
